Florian Hillen is the Founder and  CEO of VideaHealth, an AI-powered platform designed to enhance dental care by improving diagnostic accuracy, streamlining workflows, and supporting patient outcomes ...

The dental membrane and bone graft substitutes market is poised for significant growth in the coming ... and it is projected to advance at a CAGR of 15.1% from 2022 to 2031 and reach more than US$ 7.9 ...

From enhancing diagnostics to personalizing treatment plans, AI is transforming dentistry by improving efficiency, accuracy, ...

Osteoporosis treatment involves the use of effective osteoporosis medications to slow bone loss, increase bone density, and lower the risk of fractures. Fortunately, there are several categories of ...

A new study reveals a potential link between levothyroxine, a common treatment for underactive thyroid, and bone loss in older adults. Researchers found that even with normal thyroid hormone ...

A drug called levothyroxine, the second-most-commonly prescribed medication among older U.S. adults, has been linked to a higher risk of bone loss in a new study. Levothyroxine is prescribed to ...

Scientists from the Chinese Academy of Sciences (CAS) have uncovered compelling evidence suggesting that aging might be more ...

Learn about our editorial policies A capital loss occurs when you sell a capital asset for less than you bought it. It's never fun to lose money on an investment, but declaring a capital loss on ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The thyroid medication levothyroxine may be associated with bone loss, according to a study that will be presented at ...

Prescription weight loss medications, including GLP-1 agonists, orlistat, and Contrave, may be effective for some people. But other lifestyle changes are still necessary for long-term success.

A popular thyroid medication taken by 23 million Americans may be associated with bone loss, a startling new study finds. Levothyroxine — marketed under brand names such as Synthroid — is the ...